A recently published scientific study from Lund University by lead researcher Charlotte Erlanson-Albertsson, MD, PhD found that subjects who were trying to lose weight and used the patented spinach extract Appethyl on a daily basis lost 43 percent more weight compared to those ingesting a placebo.
In this clinical trial, overweight women were given either a daily five gram dose of Appethyl or a control drink immediately before breakfast. Researchers found that the weight of the women ingesting Appethyl decreased significantly at 43 percent more than subjects ingesting the control drink.
This is one of three studies that also compared the effects of Appethyl after 90 days with those found after the first dose and found no decline of effects, indicating that Appethyl takes effect after the first dose and is just as effective after long-term use. One study showed that Appethyl reduced hunger by 25 percent four hours after consumption, in addition to reducing thoughts about food by 33 percent.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7426951-appethyl-spinach-extract/
Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that many retina specialists throughout the U.S. are now using ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema (DME). The first injections of ILUVIEN in the U.S. were captured during a live web event attended by more than 250 eye care professionals. ILUVIEN is the first multiyear eye implant designed to deliver a continuous, submicrogram daily dose of steroid to the retina for 36 months with one injection. ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7496251-iluvien-dme/
For families who have a dependent with special needs, financial planning often takes a back seat to the necessities of daily life; but it also bears an increased importance.
“April’s Autism Awareness Month offers a great opportunity to emphasize the importance of planning for families who are caring for a dependent child, sibling or spouse with special needs,” said Ruthann Driscoll, JD, CLU, CFP®, director of advanced planning at Northwestern Mutual. “Crafting a comprehensive plan that addresses the needs of the dependent with special needs — for today and for tomorrow — and balancing that with the needs of the rest of the family is essential to achieving lifelong financial security.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7422151-northwestern-mutual-autism-awareness/
Novartis announced today that the US Food and Drug Administration (FDA) has approved Jadenu™ (deferasirox) tablets, a new oral formulation of Exjade® (deferasirox) tablets for oral suspension, for the treatment of chronic iron overload due to blood transfusions in patients 2 years of age and older, and chronic iron overload in non-transfusion-dependent thalassemia syndromes (NTDT) in patients 10 years of age and older. Jadenu is the only once-daily oral iron chelator that can be swallowed whole.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7440151-novartis-jadenu-fda-approval/
Since the beginning of the year French Open champion Maria Sharapova has been competing for titles on the tennis tour. Before she left to start the new season, the Porsche brand ambassador did a few laps in a Porsche 911 Turbo S – and unveiled her formula for success.
Break of dawn in Los Angeles: The beach is still deserted at that time. Only Maria Sharapova is already on her feet, ready for her daily workout. Fitness is not the only key to her success. The tennis ace emphasizes mental strength. "As long as you put in all your power, your faith and your creativity, you can win every match", she says in a recent video for Porsche.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7446051-porsche-sharapova-key-success/
Results from a large retrospective data analysis published in the American Journal of Transplantation (AJT) today, showed that liver transplantation patients who were treated early with Advagraf experienced a significantly increased graft survival benefit of 8% at 3 years post-transplant compared with patients treated with the current standard of care, tacrolimus immediate release (twice daily).
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7451251-advagraf-prolonged-release-tacrolimus/
After learning that more than 80 million Americans are living with heart disease, Mrs. Claus decided it was time that she and Santa make a change. She now creates a daily regimen for the Claus household filled with heart healthy meals and activities, including, of course, milk fortified with omega-3s and joining in the reindeer games.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7183432-heart-healthier-holiday-dsm/
BioPharmX Corporation (OTCQB: BPMX) today announced the availability of Violet™ iodine, a new, once-daily pill for relief of premenstrual breast discomfort. The first-of-its-kind product is based on the latest molecular iodine technology designed to help free women from the burden of breast discomfort by addressing the underlying causes of a condition known as fibrocystic breast condition (FBC), with the added benefit of promoting breast health for women of reproductive age.*
*These statements have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7378951-biopharmx-introducing-violet-iodine-premenstrual-breast-discomfort/
1 in 3 women will notice hair thinning in her lifetime, and it can start as early as her 20’s. Today, the hair regrowth category leader, ROGAINE® Brand, announced the official launch to market of Women's ROGAINE® 5% Minoxidil Topical Aerosol, the first and only FDA-approved, once-daily use treatment for Female Pattern Hair Loss containing 5 percent minoxidil in an elegant foam formula. Minoxidil is the only topical ingredient FDA-approved to help regrow hair.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7368851-introducing-women-s-rogaine-5-percent-minoxidil-topical-aerosol-fda-approved/
Janssen-Cilag International NV (Janssen) announced today that the European Commission has approved IMBRUVICA™ (ibrutinib) capsules, a first-in-class, once-daily, oral Bruton’s tyrosine kinase (BTK) inhibitor. This new approach to treating blood cancers works by blocking BTK, a protein that helps certain cancer cells live and grow.1 IMBRUVICA is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL), or adult patients with chronic lymphocytic leukaemia (CLL) who have received at least one prior therapy, or in first line in the presence of 17p deletion or TP53 mutation in patients unsuitable for chemo-immunotherapy.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762540-janssen-ec-approval-imbruvica-mcl-cll/
Thousands of teens from more than 3,200 high schools across the U.S. and Canada are committing to safe driving as part of the State Farm Celebrate My Drive® program. During Teen Driver Safety Week, high school students, staff and community members are encouraged to visit celebratemydrive.com once daily between 12 a.m. CT on October 15, 2014 through 11:59 p.m. CT on October 24, 2014 and commit to safe driving. The high schools with the most commitments will win grant money for their school, learn more about safe driving, and be one of two schools to win a private concert by The Band Perry.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7271031-state-farm-celebrate-my-drive-2014/
In a departure from the long-held industry tradition of feature wars, Whirlpool brand today announced the launch of Every day, care™, a campaign about changing the perception of how people view the daily chores necessary to care for one’s family. Too often these simple acts of cooking, cleaning and washing feel tedious and insignificant, when in fact they play a huge role in shaping the people we love and the world we live in.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7318751-whirlpool-announced-launch-of-every-day-take-the-chore-out-of-household-responsibilities/
